Bio-Techne (TECH) Cash from Investing Activities (2009 - 2026)

Bio-Techne's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$5.8 million for Q1 2026.

• On a quarterly basis, Cash from Investing Activities rose 34.44% year-over-year to -$5.8 million in Q1 2026; TTM through Mar 2026 was -$10.7 million, a 75.84% increase from a year earlier, with the FY2025 full-year figure at -$35.2 million, up 82.67% from the prior year.
• Cash from Investing Activities rose to -$5.8 million in Q1 2026 per TECH's latest filing, from -$5.9 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $605000.0 in Q3 2025 and bottomed at -$241.1 million in Q1 2023.
• The 5-year median for Cash from Investing Activities is -$8.9 million (2025), against an average of -$33.5 million.
• Across the five-year window, Cash from Investing Activities slumped 28001.55% in 2022 and surged 104.61% in 2025, its largest moves.
• Year by year, Cash from Investing Activities stood at -$109000.0 in 2022, then plunged by 21616.51% to -$23.7 million in 2023, then surged by 78.74% to -$5.0 million in 2024, then slipped by 17.67% to -$5.9 million in 2025, then grew by 1.76% to -$5.8 million in 2026.
• Per Business Quant, the three latest TECH Cash from Investing Activities figures stand at -$5.8 million (Q1 2026), -$5.9 million (Q4 2025), and $605000.0 (Q3 2025).